| 1 |
Thomson P, Hammond S, Naisbitt DJ. Pathology of drug hypersensitivity reactions and mechanisms of immune tolerance. Clin Exp Allergy 2022;52:1379-90. [PMID: 36177544 DOI: 10.1111/cea.14235] [Reference Citation Analysis]
|
| 2 |
Deshpande P, Li Y, Thorne M, Palubinsky AM, Phillips EJ, Gibson A. Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity. J Allergy Clin Immunol Pract 2022;10:1689-700. [PMID: 35526777 DOI: 10.1016/j.jaip.2022.04.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Fernandez-Santamaria R, Ariza A, Fernandez TD, Cespedes JA, Labella M, Mayorga C, Torres MJ. Advances and highlights in T and B cell responses to drug antigens. Allergy 2022;77:1129-38. [PMID: 34617287 DOI: 10.1111/all.15126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Pichler WJ. The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions. Allergy 2022;77:404-15. [PMID: 34037262 DOI: 10.1111/all.14962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Saper VE, Ombrello MJ, Tremoulet AH, Montero-Martin G, Prahalad S, Canna S, Shimizu C, Deutsch G, Tan SY, Remmers EF, Monos D, Hahn T, Phadke OK, Cassidy E, Ferguson I, Mallajosyula V, Xu J, Rosa Duque JS, Chua GT, Ghosh D, Szymanski AM, Rubin D, Burns JC, Tian L, Fernandez-Vina MA, Mellins ED, Hollenbach JA; Drug Hypersensitivity Consortium., INCHARGE Consortium. Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles. Ann Rheum Dis 2021:annrheumdis-2021-220578. [PMID: 34789453 DOI: 10.1136/annrheumdis-2021-220578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 6 |
Bechara R, Feray A, Pallardy M. Drug and Chemical Allergy: A Role for a Specific Naive T-Cell Repertoire? Front Immunol 2021;12:653102. [PMID: 34267746 DOI: 10.3389/fimmu.2021.653102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Thomson PJ, Kafu L, Meng X, Snoeys J, De Bondt A, De Maeyer D, Wils H, Leclercq L, Vinken P, Naisbitt DJ. Drug-specific T-cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat. Allergy 2021;76:1825-35. [PMID: 33150583 DOI: 10.1111/all.14652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Hertzman RJ, Deshpande P, Gibson A, Phillips EJ. Role of pharmacogenomics in T-cell hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2021;21:327-34. [PMID: 34039850 DOI: 10.1097/ACI.0000000000000754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Hammond S, Thomson P, Meng X, Naisbitt D. In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs. Front Immunol 2021;12:630530. [PMID: 33927714 DOI: 10.3389/fimmu.2021.630530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int J Mol Sci 2021;22:2954. [PMID: 33799477 DOI: 10.3390/ijms22062954] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 11 |
Büyük Yaytokgil Ş, Güvenir H, Külhaş Celík İ, Yilmaz Topal Ö, Karaatmaca B, Civelek E, Toyran M, Dibek Misirlioğlu E. Evaluation of drug patch tests in children. Allergy Asthma Proc 2021;42:167-74. [PMID: 33685563 DOI: 10.2500/aap.2021.42.200110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 12 |
Hsu YO, Lu KL, Fu Y, Wang CW, Lu CW, Lin YF, Chang WC, Yeh KY, Hung SI, Chung WH, Chen CB. The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity. Front Immunol 2021;12:597761. [PMID: 33717075 DOI: 10.3389/fimmu.2021.597761] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Hollenbach J, Ombrello MJ, Tremoulet A, Duque JSR, Chua GT, Montero-martin G, Burns JC, Shimizu C, Deutsch G, Monos D, Mallajosyula V, Xu J, Ghosh D, Tan S, Remmers E, Canna S, Szymanski AM, Rubin D, Fernandez-vina MA, Saper VE, Mellins ED, Drug Hypersensitivity in sJIA Consortium investigators. Hypersensitivity reactions to IL-1 and IL-6 inhibitors are linked to common HLA-DRB1*15 alleles.. [DOI: 10.1101/2020.08.10.20172338] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Iulini M, Maddalon A, Galbiati V, Marinovich M, Corsini E. In vitro identification of drugs inducing systemic hypersensitivity reactions known in vivo to be associated with specific HLA genotypes. Toxicol In Vitro 2020;68:104953. [PMID: 32730864 DOI: 10.1016/j.tiv.2020.104953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
